Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2552 (LINC02552)

Target
LINC02552
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2552 (LINC02552) is a human long intergenic non-coding RNA (lincRNA), transcribed as a non-protein coding RNA product longer than 200 nucleotides and located outside of protein-coding loci[1][3]. LINC02552 is annotated in the NCBI (Gene ID: 102723895) and Ensembl (ENSG00000256422) databases, but there is currently no published evidence indicating functional characterization, disease association, or therapeutic targeting of this specific lincRNA in the biomedical literature. In general, lincRNAs act through diverse mechanisms to fine-tune gene expression, remodel chromatin, and participate in tissue-specific regulatory networks, but most individual lincRNAs, including LINC02552, remain poorly characterized with respect to their biological functions and disease relevance[3][5]. **Key points:** - LINC02552 is a lincRNA, not a protein, receptor, enzyme, or established drug target[1][3]. - There is no evidence for direct therapeutic relevance, biomarker use, or disease association for LINC02552 as of current database and literature knowledge[1][3][5]. - Its molecular and biological role, if any, remains to be determined, but it can be classified generically as a member of the lincRNA family.

Other names
LINC02552
02

Biological functions

Regulation of gene expression (by analogy to lincRNAs generally)[3][5]Chromatin remodeling (by analogy)[3]Transcriptional regulation (by analogy)[3]RNA stabilization (by analogy)[3]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2552 (LINC02552).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2552 (LINC02552).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call